Therapeutic potential of HO-1 in autoimmune diseases

Inflammation. 2014 Oct;37(5):1779-88. doi: 10.1007/s10753-014-9908-z.

Abstract

Heme oxygenase-1 (HO-1), the inducible isoform of heme oxygenase (HO), has raised a lot of concerns in recent years due to its multiple functions. HO-1 was found to be a pivotal cytoprotective, antioxidant, anti-apoptotic, immunosuppressive, as well as anti-inflammatory molecule. Recent studies have clarified its significant functions in many diseases with substantial findings. In autoimmune diseases, HO-1 may have promising therapeutic potential. Here, we briefly reviewed recent advances in this field, aiming at hopefully exploring the potential therapeutic roles of HO-1, and design HO-1-based strategies for the treatment of autoimmune diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Autoimmune Diseases / drug therapy*
  • Autoimmune Diseases / enzymology
  • Heme Oxygenase-1 / pharmacology
  • Heme Oxygenase-1 / therapeutic use*
  • Humans
  • Inflammation / drug therapy
  • Inflammation / enzymology
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology

Substances

  • Anti-Inflammatory Agents
  • Heme Oxygenase-1